- Home
- ACI vs HALO Comparison
ACI vs HALO Comparison
Compare ACI & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACI | HALO |
|---|---|---|
| Founded | 1860 | 1998 |
| Country | United States | United States |
| Employees | 270000 | N/A |
| Industry | Food Chains | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 8.8B |
| IPO Year | 2015 | 2001 |
Fundamental Metrics
Financial Performance| Metric | ACI | HALO |
|---|---|---|
| Price | $17.18 | $63.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 11 |
| Target Price | $22.29 | ★ $78.18 |
| AVG Volume (30 Days) | ★ 5.1M | 1.8M |
| Earning Date | 04-07-2026 | 05-11-2026 |
| Dividend Yield | ★ 3.56% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.25 | ★ 2.56 |
| Revenue | ★ $80,390,900,000.00 | $151,862,000.00 |
| Revenue This Year | $4.69 | $28.24 |
| Revenue Next Year | N/A | $12.79 |
| P/E Ratio | ★ $13.55 | $24.83 |
| Revenue Growth | ★ 1.46 | N/A |
| 52 Week Low | $15.80 | $47.50 |
| 52 Week High | $23.20 | $82.22 |
Technical Indicators
Market Signals| Indicator | ACI | HALO |
|---|---|---|
| Relative Strength Index (RSI) | 46.83 | 28.72 |
| Support Level | $16.91 | $61.23 |
| Resistance Level | $17.74 | $65.40 |
| Average True Range (ATR) | 0.48 | 1.87 |
| MACD | -0.12 | -0.73 |
| Stochastic Oscillator | 32.30 | 5.17 |
Price Performance
Historical ComparisonAbout ACI Albertsons Companies Inc.
Albertsons is the second-largest supermarket operator in the United States with about 2,300 stores across a variety of banners. Around 80% of the firm's sales comes from nonperishable and fresh food, of which 26% comes from its portfolio of private brands. The company operates fuel centers at about 20% of its store locations and pharmacies at 75%. Albertsons went public in 2020 following years of ownership under private equity firm Cerberus Capital Management, which still owns about a fourth of the outstanding shares.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.